Serum malondialdehyde (MDA) level as a potential biomarker of cancer progression for patients with bladder cancer
Authors
Zahid Lepara
Urology Clinic, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina
Orhan Lepara
Department of Physiology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina
Almir Fajkić
Department of Pathophysiology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina
Damir Rebić
Nephrology Clinic, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina
Jasmin Alić
Urology Clinic, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina
Hajrudin Spahović
Urology Clinic, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina
Language: English
Page range: 146 - 152
Submitted on: Feb 14, 2020
Published on: Aug 10, 2020
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2020 Zahid Lepara, Orhan Lepara, Almir Fajkić, Damir Rebić, Jasmin Alić, Hajrudin Spahović, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.